| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – Nov. 5, 2026 – Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced its third-quarter 2026 financial results. |
| 08 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
This Agreement and Plan of Merger (this “Agreement”) is made and entered into as of October 8, 2026 (the “Agreement Date”), by and among Viatris Inc., a Delaware corporation (“Parent”), Peach Purchaser Sub Inc., a Delaware corporation an... |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – August 6, 2026 – Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced its second-quarter 2026 financial results. |
| 01 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
Form of U.S. Tax Compliance Certificate (For Foreign Lenders That Are Not Partnerships For U.S. Federal Income Tax Purposes) |
| 18 Jun 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
SENIOR INDENTURE, dated as of June 17, 2026, among Viatris Inc., a Delaware corporation, as issuer, the Guarantors (as defined in Section 1.01) and The Bank of New York Mellon, a New York banking corporation, as trustee. |
| 15 Jun 2026 |
8-K: Other Events
Viatris Inc., a Delaware corporation (the “Issuer”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom BNP PARIBAS, Citigroup Global Markets Limited and Goldman Sachs & Co. LLC (each a... |
| 15 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
(a) On May 15, 2026, Viatris Inc. (“Viatris” or the “Company”) held its 2026 annual meeting of shareholders (the “2026 Annual Meeting”). At the 2026 Annual Meeting, shareholders were asked to consider and act upon the following items of ... |
| 07 May 2026 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – May 7, 2026 – Viatris Inc. (Nasdaq: VTRS) today announced its first-quarter 2026 financial results. |
| 04 May 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Theodora “Doretta” Mistras to Depart; Paul Campbell Named Interim CFO |
| 26 Feb 2026 |
8-K: Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities +1 more
PITTSBURGH – February 26, 2026 – Viatris Inc. (Nasdaq: VTRS) today announced robust financial results for the fourth quarter and full year 2025. The Company also announced it has completed its enterprise-wide strategic review and expects... |
| 03 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 3, 2026, Viatris Inc. (the “Company”) announced that Brian Roman, Chief Legal Officer of the Company, would transition from his role with the Company and cease to serve as Chief Legal Officer effective as of February 9, 2026.... |
| 08 Dec 2025 |
8-K: Regulation FD Disclosure
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited |
| 05 Dec 2025 |
8-K: Submission of Matters to a Vote of Security Holders
(a) On December 5, 2025, Viatris Inc. (“Viatris” or the “Company”) held its 2025 annual meeting of shareholders (the “2025 Annual Meeting”) to (i) elect thirteen director nominees, each to hold office until the 2026 annual meeting of sha... |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – November 6, 2025 – Viatris Inc. (Nasdaq: VTRS) today reported strong third quarter 2025 financial results and updated full-year financial guidance. |
| 24 Oct 2025 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Shareholder Director Nominations +1 more
Section 1.1 Place of Meetings. The Board of Directors or the Chair of the Board of Directors may designate the place of meeting for any annual or special meeting of the stockholders and the Board of Directors may also designate that the ... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – August 7, 2025 – Viatris Inc. (Nasdaq: VTRS) today reported strong second quarter 2025 financial results and reiterated its 2025 financial guidance ranges across all metrics. |
| 05 Aug 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
PITTSBURGH – August 5, 2025 – Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that David Simmons has been appointed as the newest member of Viatris’ Board of Directors. |
| 08 May 2025 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – May 8, 2025 – Viatris Inc. (Nasdaq: VTRS) today reported first quarter 2025 financial results and reaffirmed its 2025 outlook[1]. |
| 05 May 2025 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
PITTSBURGH – May 5, 2025 – Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that as part of its ongoing Board refreshment efforts, Frank D’Amelio and Michael Severino, M.D., have been appointed as the newest memb... |
| 27 Feb 2025 |
8-K: Results of Operations and Financial Condition; Other Events
PITTSBURGH – February 27, 2025 – Viatris Inc. (Nasdaq: VTRS) today announced strong financial results for the fourth quarter and full year 2024—including divestiture-adjusted operational revenue growth of 2% for the full year with growth... |
Loading...